It's too early to rejoice
So far, only the tolerability of the Russian COVID-19 vaccine and how much it causes the formation of antibodies have been studied
Vasily Vlasov, Professor at the Higher School of Economics, Vice President of the Society for Evidence-Based Medicine, argues that the Russian COVID-19 vaccine has formed an immune response in volunteers:
We don't know anything about the effectiveness of this vaccine. Let me remind you that a vaccine is a special biological drug that must be tested for its ability to protect against infection and approved for use. Until everything is thoroughly tested and approved for use, the vaccine is called "candidate".
Now we are dealing with the propaganda of premature messages. In fact, the second phase of testing has not yet been completed. However, for the third or fourth time, a wave is rising with reports that the vaccine is already working. In fact, only the tolerability of the vaccine and how much it causes the formation of antibodies have been studied so far. According to media reports, which rely on data from the manufacturer, it is known that the vaccine is not well tolerated. The army men report that everything is fine, but the Sechenov Academy gives information that people get sick after its introduction.
As for antibodies, they are formed. The problem is that the formation of antibodies does not necessarily mean the presence of immunity. Antibodies are an indirect sign. It is necessary to conduct normal clinical trials that will prove that the vaccine protects. This is the longest and most difficult stage of the work. Now it is necessary in the region of the Russian Federation, where the incidence is high, to vaccinate one group of people, and not the other, and compare how much the vaccinated will have a better result. Only after that it will be possible to say that the vaccine works, but you need to work for at least a few more months before such a result.
Portal "Eternal youth" http://vechnayamolodost.ru